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1. Introduction 
Thyroid-stimulating hormone (TSH) and the 
thyroid-stimulating immunoglobulin described as 
long acting thyroid-stimulator (LATS) have been 
shown to bind to receptors in the thyroid [1 -6] .  
However, reports on the interaction of immunoglo- 
bulins with LATS activity on the binding of labelled 
TSH to its receptor appear to be conflicting. Fayet 
et al. [5] have reported that LATS serum incom- 
pletely inhibited the binding of labelled TSH to 
intact thyroid cells whereas Amir et al. [6] were 
unable to demonstrate any action of LATS on TSH 
binding to isolated thyroid membranes. 
This paper describes the effects of immunoglo- 
bulins from several LATS sera on the binding of 
labelled TSH to thyroid membranes. 
2. Methods and results 
Highly purified bovine TSH (30 U/rag; a generous 
gift from Dr. J.G.Pierce), was labelled [7] with 125I 
to a specific activity of 100/aCi/~g. Bovine serum 
albumin (10 mg) was added as carrier protein and 
the mixture chromatographed on a column of 
Sephadex G-100 in 50 mM NaCI; 10 mM Tris pH 
7.5 (Tris-NaC1) to remove small amounts of aggre- 
gate and free iodide. The purified label was then 
stored at -30°C. 
Crude guinea pig thyroid membranes were pre- 
pared from tissue slices. The slices were homogenised 
in a glass homogeniser with cold 10 mM Tris pH 7.5 
and the homogenate centrifuged at 500g for 5 rain. 
The supernatant was centrifuged further at 10 000g 
for 1 5 min and the sedimented membrane fraction 
resuspended in Tris NaC1 containing 1 mg/ml of 
bovine serum albumin (Tris-NaC1-BSA) and 
stored at 0°C for up to 12 hr. The membranes 
obtained from t mg of tissue were defined as 1 mg 
equivalent. 
Immunoglobulins were precipitated from serum 
by addition of 3.75 M ammonium sulphate to a 
final concentration of 1.6 M. The precipitate was 
washed twice with 1.6 M ammonium sulphate and 
dissolved in distilled water (about 50% of the 
original serum volume). After dialysis against Tris-  
NaC1, the protein solution was centrifuged at 
100 000g for 15 min and stored at 4°C for up to 
two months. Preparations Ba, Ro, Col Wi, Wr, Mi 
and Ay were from patients with Graves' disease. 
A pool of serum from 10 healthy donors was used 
to prepare normal immunoglobulins. Thyroid 
stimulating activity was determined by the McKenzie 
method [8] (table 1). 
Table 1 
McKenzie assay responses to immunoglobulin preparations 
Patient IgG dose (mg./mouse) Assay response 
(% with S.E.M.) 
Ba 0.25 815 ± 90 
Ro 0.25 995 ± 100 
Co 1 1166 -+ 130 
Wi 12 1053 -+ 270 
Wr 12 358 -+ 60 
Mi 12 93 ± 6 
Ay 12 85 ± 9 
Normal 12 64 ± 12 
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Membranes (20/A of 200 mg equivalent/ml) 
were incubated for 5 min at 37°C with 200/ll of 
Tris-NaC1 BSA containing cold bovine TSH 
(1 U/mg, kindly supplied by Armour Pharmaceuti- 
cals) or immunoglobulins. Labelled TSH (about 30 
pg in 100 #1 of Tris-NaC1-BSA) was then added 
and the incubation continued for 1-2 hr. The mix- 
tures were then cooled to 0°C and, after addition of 
1 ml ofTris NaC1-BSA, centrifuged at 15 000g for 
15 rain. All determinations were made in triplicate. 
Under these conditions, about 7% of the labelled 
TSH was bound to membranes in the absence of any 
cold TSH (fig. 1). Seventy five per cent of the bound 
TSH could be eluted by treatment with 2 M NaSCN 
[31 and after removal of the NaSCN by dialysis or 
gel filteration about 3ff/~ of the eluted material was 
bound to thyroid membranes on reincubation 
(fig. 1). 
This receptor purified material was used in all 
subsequent experiments. It was stored at -30°C and 
used within 3 days of preparation. 
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Fig. 2. Binding of 12s l-labelled TSH to thyroid membranes 
shown as a Scatchard Plot. The negative slope gives the asso- 
ciation constant (2.6 × 101° molar-1 ) and the amount 
bound at bound/free = 0 gives the binding capacity of the 
membranes (1.2 ~zU equivalents/mg equivalent). 
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Fig. 1. Binding of 12SI-labelled TSH to thyroid membranes. 
(at _at) Label used before receptor purification. (o o) 
Recopt.or purified label. 
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The binding of receptor purified label to thyroid 
membranes was significantly inhibited by less than 
3/aU of cold TSH (fig. 1). The Scatchard analysis 
[9] shown in fig. 2 indicated asingle population of 
binding sites with an association constant of 2.6 × 
101 o molar-1 and showed that the crude membrane 
fraction contained 1.2/aU equivalents of receptors 
in each mg equivalent. 
The effects of preincubating the thyroid mem- 
branes with immunoglobulins from different sera 
are shown in fig. 3. Normal immunoglobulins inhibi- 
ted TSH binding to small extent and in a non dose 
dependant manner. Immunoglobulin preparation 
(Ba) with high LATS activity (table 1) completely 
inhibited TSH binding whereas preparation (Ro) 
with similar LATS activity to (Ba) was less effective 
in the receptor assay. 
Immunoglobulins (Wi) and (Wr) with far lower 
LATS titres than (Ro) showed similar effects to 
(Ro) in inhibiting TSH binding. With preparation 
(Mi) (LATS negative) increasing the dose of immuno- 
globulin increased the amount of TSH bound to the 
membranes and (Ro), (Wi) and (Wr) showed inhibi- 
tion of TSH binding at low doses and potentiation at 
high doses. Immunoglobulin (Ay) with no detectable 
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Fig. 3. Effect of immunoglobulins from patients with Graves' 
disease on the binding of 12SI-labelled TSH to thyroid 
membranes. Two separate xperiments are shown. Immuno- 
globulins (Mi) and (Ba) were included in both studies. 
LATS activity showed a small but significant 
inhibition of binding. 
thyroid cell surface sites related to the TSH receptor. 
Different sera probably contained ifferent antibody 
concentrations, affinities and specificities and in this 
context different immunoglobulin preparations might 
have been expected to give different dose response 
effects in the TSH receptor assay. Similarly, lack 
of correlation between the mouse bioassay and the 
guinea pig receptor system probably reflected species 
difference and artifacts of the indirect in vitro binding 
situation. 
The ability of  some immunoglobulins to enhance 
TSH binding to thyroid membranes was apparently 
similar to the reported potentiation of TSH binding 
to retre-orbital tissue membranes by immunoglobulins 
from patients with Graves' disease [ I0].  It was diffi- 
cult to rationalise these observations but possibly an 
antigen-antibody interaction close to the TSH receptor 
induced changes in the membrane which altered 
availability, specificity or affinity of the TSH recep- 
tor sites. A combination of direct competition for the 
TSH receptor with an indirect enhancing effect could 
have been responsible for some immunoglobulins 
showing inhibition of binding at low doses and 
potentiation of binding at high doses. 
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3. Discussion 
Immunoglobulins from patients with Graves' 
disease inhibited TSH binding to thyroid membranes 
but dose-response lines from different immunoglo- 
bulins were non parallel and the ability of particular 
preparations to inhibit TSH binding did not correlate 
with their LATS activity as measured by McKenzie 
bioassay (table 1). 
This data suggested that the immunoglobulins 
contained a population of antibodies directed towards 
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